CEO Schorgl quoted in MD+DI’s look ahead at 2026
John Schorgl shares insights on 2026 medtech trends
In their article "The Medtech Landscape in 2026: Here’s What to Expect," MD+DI spoke with five industry experts, including Peytant's CEO John Schorgl, about what to expect from the medtech space in 2026, and what will be different from 2025.